Vilvet Pharmaceuticals Inc. recalls VILEVEV MB Urinary Antispetic (81.0 mg methenamine, 40.8 mg sodium phosphate monobasic and 10.8 mg methylene blue, 0.12
Recalled August 12, 2020 · FDA recall D-1488-2020 · Vilvet Pharmaceuticals
Hazard
cGMP deviations · FDA Class II
Units
1,716 bottles
Sold at
Nationwide within the US
Description
cGMP deviations
Product
VILEVEV MB Urinary Antispetic (81.0 mg methenamine, 40.8 mg sodium phosphate monobasic and 10.8 mg methylene blue, 0.12 mg hyoscyamine sulfate and 32.4 mg phenyl salicylate), Rx Only, 90 Tablets per Bottle, Manufactured for: Vilvet Pharmaceuticals, Inc., Chester Springs, PA 19425, NDC 71186-000-24.
Manufacturer(s)
Vilvet Pharmaceuticals Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →